Cargando…
Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer
Plasma exosomal miRNAs were evaluated for prognosis in an initial set of 44 metastatic renal cell cancer (mRCC) patients by RNA sequencing. Among ∼3.49 million mappable reads per patient, miRNAs accounted for 93.1% of the mapped RNAs. 227 miRNAs with high abundance were selected for survival analysi...
Autores principales: | Du, Meijun, Giridhar, Karthik V., Tian, Yijun, Tschannen, Michael R., Zhu, Jing, Huang, Chiang-Ching, Kilari, Deepak, Kohli, Manish, Wang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609954/ https://www.ncbi.nlm.nih.gov/pubmed/28969022 http://dx.doi.org/10.18632/oncotarget.19476 |
Ejemplares similares
-
Plasma cell-free DNA–based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer
por: Du, Meijun, et al.
Publicado: (2020) -
Characterization of human plasma-derived exosomal RNAs by deep sequencing
por: Huang, Xiaoyi, et al.
Publicado: (2013) -
Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer
por: Huang, Jinyong, et al.
Publicado: (2022) -
No Significant Difference between Plasma miRNAs and Plasma-Derived Exosomal miRNAs from Healthy People
por: Tian, Fei, et al.
Publicado: (2017) -
Detection of Exosomal miRNAs in the Plasma of Melanoma Patients
por: Pfeffer, Susan R., et al.
Publicado: (2015)